XWELL, Inc. Files Proxy Statement
Ticker: XWEL · Form: DEFA14A · Filed: Aug 13, 2024 · CIK: 1410428
| Field | Detail |
|---|---|
| Company | Xwell, Inc. (XWEL) |
| Form Type | DEFA14A |
| Filed Date | Aug 13, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, corporate-governance
TL;DR
XWELL proxy filing is out, shareholders need to vote.
AI Summary
XWELL, Inc. filed a Definitive Proxy Statement (DEFA14A) on August 13, 2024. This filing is a solicitation of proxies under Rule 14a-12, indicating it contains material for soliciting proxies from shareholders. The company, formerly known as XpresSpa Group, Inc. and Form Holdings, Inc., is headquartered in New York.
Why It Matters
This filing is important for shareholders as it outlines the company's proposals and provides information necessary for them to vote on important corporate matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not inherently present new financial risks.
Key Players & Entities
- XWELL, Inc. (company) — Registrant
- XpresSpa Group, Inc. (company) — Former Company Name
- Form Holdings, Inc. (company) — Former Company Name
- 20240813 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for XWELL, Inc.?
This DEFA14A is a Definitive Proxy Statement filed by XWELL, Inc. on August 13, 2024.
Is this filing a preliminary or definitive proxy statement?
This is a Definitive Proxy Statement, as indicated by the checkmark next to 'Definitive Proxy Statement' and 'Soliciting Material under §240.14a-12'.
What are some former names of XWELL, Inc. mentioned in the filing?
XWELL, Inc. was formerly known as XpresSpa Group, Inc. and Form Holdings, Inc.
When was the filing submitted to the SEC?
The filing was submitted on August 13, 2024.
What is the business address of XWELL, Inc.?
The business address of XWELL, Inc. is 254 West 31st Street, 11th Floor, New York, NY 10001.
Filing Stats: 1,030 words · 4 min read · ~3 pages · Grade level 15.3 · Accepted 2024-08-13 17:25:39
Filing Documents
- tm2421633-1_defa14a.htm (DEFA14A) — 20KB
- 0001104659-24-089059.txt ( ) — 21KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No . ) Filed by the Registrant Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement o Definitive Additional Materials Soliciting Material under §240.14a-12 XWELL, Inc. (Name of Registrant as Specified in its Charter) (Name Of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required o Fee paid previously with preliminary materials o Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 On August 13, 2024, XWELL, Inc. issued the below press release: XWELL Comments on CPC’s Withdrawal of Threatened Proxy Fight and Related Lawsuit NEW YORK, August 13, 2024 -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today issued the following statement in response to CPC Pain & Wellness SPV, LLC’s (“CPC”) decision to withdraw its threatened proxy fight and related lawsuit against XWELL, in connection with the Company’s 2024 annual meeting of stockholders (the “2024 Annual Meeting”). Bruce Bernstein, Chairman of the Board stated, “We are pleased that CPC decided to withdraw its threatened proxy fight and lawsuit against XWELL related to our 2024 Annual Meeting. Looking ahead, we are fully focused on delivering on our strategic plan to drive durable, long-term value creation for stockholders. We are appreciative of the constructive engagement we’ve had with stockholders to-date and look forward to continued engagement with them leading up to XWELL’s 2024 Annual Meeting.” About XWELL, Inc. XWELL, Inc. (Nasdaq: XWEL) is a leading global wellness holding company operating multiple brands: XpresSpa ® , Treat™, Naples Wax Center ® , XpresCheck ® and HyperPointe™. · XpresSpa is a leading retailer of wellness services and related products, with 33 locations in 16 airports globally. · Naples Wax Center is a group of upscale skin care boutiques, with three locations currently operating. · XpresCheck is a provider of screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo, conducting bio surveillance monitoring in its airport locations to identify new SARS-CoV-2 variants of interest and concern as well as other pathogens entering the country from across the world. · HyperPointe is a leading digital healthcare and data analytics relationship company serving the global healthcare industry. Contacts Longacre Square Partners Jessica McDougall / Christina Spellman, (646) 386-0091 XWELL@longacresquare.com Forward Looking This press release may contain “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “should,” “seeks,” "future,” “continue,” or the negative of such terms, or other comparable terminology. Forward-looking are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and other SEC filings (which reports were filed under the Company’s former name, XpresSpa Group, Inc., prior to its previously announced name change effective October 25, 2022). All subsequent written and oral forward-looking statements concerning XWELL, or other matters and attributable to XWELL or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XWELL does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof. Important Additional Information The Company intends to file a definitive proxy with the 2024 Annual Meeting. STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ SUCH PROXY STATEMENT, ACCOMPANYING WHITE PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE 2024 ANNU